Megharani Mahajan
Postdoctoral Research Fellow · UT Health San Antonio
https://researchid.co/mahajanm
@uthscsa.edu
8Scopus Publications
126Google Scholar Citations
4Google Scholar h-index
2Google Scholar i10-index
Biography
Postdoctoral researcher in cancer biology with expertise in redox signaling, tumor progression, and therapeutic resistance, particularly in breast cancer. My work focuses on molecular mechanisms of oncogenic signaling, tumor microenvironment interactions, and identification of novel therapeutic targets in triple-negative breast cancer and hormone receptor signaling pathways.
Education
Ph.D. in Biotechnology (Cancer Biology) from National Centre for Cell Science, Pune, 2022 M.Sc. in Biotechnology from Gulbarga University, 2009 B.Sc. in Biotechnology from Gulbarga University, 2007
Recent Scopus Publications
- EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling
- The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
- Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis
- PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
- Novel LIPA-Targeted Therapy for Treating Ovarian Cancer
Links
- ORCID https://orcid.org/0000-0002-6259-5754
- Google Scholar https://scholar.google.com/citations?user=OYOUQJ8AAAAJ
- Scopus https://www.scopus.com/authid/detail.uri?authorId=57221652399
- Personal Weblink https://vidwan.inflibnet.ac.in/myprofile